2-[8-chloro-4-(difluoromethoxy)-2-ethyl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-5-yl]oxyacetic acid
C24H20ClF2N3O4 — CID 25095817
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[8-chloro-4-(difluoromethoxy)-2-ethyl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-5-yl]oxyacetic acid
2-[8-chloro-4-(difluoromethoxy)-2-ethyl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-5-yl]oxyacetic acid (PubChem CID 25095817) has the molecular formula C24H20ClF2N3O4 and a molecular weight of 487.89 g/mol. Its IUPAC name is 2-[8-chloro-4-(difluoromethoxy)-2-ethyl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-5-yl]oxyacetic acid.
Molecular Properties
| Compound Name | 2-[8-chloro-4-(difluoromethoxy)-2-ethyl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-5-yl]oxyacetic acid |
|---|---|
| PubChem CID | 25095817 |
| Molecular Formula | C24H20ClF2N3O4 |
| Molecular Weight | 487.89 g/mol |
| Exact Mass | 487.11 |
| IUPAC Name | 2-[8-chloro-4-(difluoromethoxy)-2-ethyl-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-5-yl]oxyacetic acid |
| SMILES | CCc1nc2c(Cl)ccc(OCC(=O)O)c2c(OC(F)F)c1Cc1ccc(-n2cccn2)cc1 |
| InChI | InChI=1S/C24H20ClF2N3O4/c1-2-18-16(12-14-4-6-15(7-5-14)30-11-3-10-28-30)23(34-24(26)27)21-19(33-13-20(31)32)9-8-17(25)22(21)29-18/h3-11,24H,2,12-13H2,1H3,(H,31,32) |
| InChIKey | JUNIRRINVMBFQC-UHFFFAOYSA-N |
| XLogP | 5.29 |
| TPSA | 86.47 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.89 |
| LogP ≤ 5 | 5.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25095817 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.